Aarey Drugs & Pharmaceuticals Ltd. - Research Center
524412 AREYDRG Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | Mar' 21 | |
|---|---|---|---|---|---|
| Sales | 120.25 | 140.27 | 134.65 | 97.52 | 178.25 |
| Operating profit | 1.86 | 3.06 | 3.42 | 2.93 | 2.36 |
| Interest | 0.61 | 0.49 | 0.61 | 0.47 | 0.56 |
| Gross profit | 2.39 | 2.70 | 3.62 | 3.13 | 3.44 |
| EPS (Rs) | 0.09 | 0.77 | 1.22 | 1.07 | 0.60 |
Quarterly
results in details
| Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | Mar' 21 | |
|---|---|---|---|---|---|
| Other income | 1.13 | 0.13 | 0.81 | 0.67 | 1.64 |
| Stock adjustment | 461.70 | 2.17 | -4.96 | 8.38 | 11.53 |
| Raw material | -351.84 | 133.03 | 134.28 | 84.53 | 163.49 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 4.21 | 0.33 | 0.13 | 0.11 | 0.40 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 4.30 | 1.69 | 1.78 | 1.58 | 0.48 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.41 | 0.50 | 0.50 | 0.40 | 0.25 |
| Taxation | 1.75 | 0.25 | 0.28 | 0.22 | 1.79 |
| Net profit / loss | 0.23 | 1.95 | 2.84 | 2.51 | 1.41 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.38 | 25.38 | 23.38 | 23.38 | 23.38 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 1.55 | 2.18 | 2.54 | 3.00 | 1.32 |
| GPM (%) | 1.97 | 1.92 | 2.68 | 3.19 | 1.91 |
| NPM (%) | 0.19 | 1.39 | 2.10 | 2.55 | 0.78 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis